Paer.Ns

PAER.NS has a debt-to-equity ratio of 1.36, indicating a moderate reliance on debt financing, and a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities. The company's liquidity position is assessed as medium, with a key flag indicating that net cash is negative after subtracting total debt.

The company's profitability is reflected in a return on equity (ROE) of 18.78% and a return on assets (ROA) of 6.6%, both of which are strong indicators of efficient use of equity and assets. These figures are to be compared against the industry's preferred metrics, which typically emphasize gross margin and operating margin as key performance indicators.

PAER.NS's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification. The company's exposure to a single business line may increase its vulnerability to market-specific risks, such as changes in consumer spending patterns or regulatory shifts in the retail sector.

The company's growth trajectory is expected to remain stable, with no significant changes in revenue forecasted for the current and next fiscal years. Historical revenue data shows a consistent performance, with no sharp increases or declines in the most recent periods.

The risk assessment for PAER.NS indicates a low potential for dilution, with no significant dilution events reported in the recent financial statements. The company's capital structure and liquidity position suggest that it is not under immediate pressure to issue new shares to fund operations or debt obligations.

Recent filings and transcripts do not indicate any major events or strategic shifts for PAER.NS. The company has not disclosed any significant legal, regulatory, or operational risks in its latest reports, and there are no notable earnings call transcripts that highlight new initiatives or challenges.